Compare FOCL & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOCL | SPOK |
|---|---|---|
| Founded | N/A | 2004 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.7M | 222.8M |
| IPO Year | 1998 | 2004 |
| Metric | FOCL | SPOK |
|---|---|---|
| Price | $4.20 | $10.66 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 199.0K | 145.4K |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | ★ 11.31% |
| EPS Growth | N/A | ★ 2.74 |
| EPS | N/A | ★ 0.29 |
| Revenue | $70,527,000.00 | ★ $139,708,000.00 |
| Revenue This Year | N/A | $1.70 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $36.93 |
| Revenue Growth | ★ 1.63 | 1.49 |
| 52 Week Low | $4.01 | $9.95 |
| 52 Week High | $6.40 | $17.67 |
| Indicator | FOCL | SPOK |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 49.09 |
| Support Level | $4.01 | $10.29 |
| Resistance Level | $4.50 | $10.78 |
| Average True Range (ATR) | 0.19 | 0.20 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 58.16 | 76.47 |
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.